Tagal, Baby Boy .

HRN: 29-06-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/29/2026
06/04/2026
IV
32MG
OD
PSNB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines